Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell
• Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
Real World Study Shows Neovasc’s Reducer Is Safe, Efficacious In Patients With Refractory Angina
Neovasc Inc (NASDAQ:NVCN) has announced the publication of an article highlighting the long-term outcomes of patients suffering from refractory angina treated…
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
BriaCell Therapeutics Corp. (NASDAQ: BCTX) shares jumped 147.3% to $7.86 after the company provided an update on the overall survival (OS) data on its previously disclosed heavily pretreated advanced breast cancer patients.
Earnings Scheduled For May 6, 2021
Companies Reporting Before The Bell
• ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions.
Novocure Announces FDA IDE Approval And Steering Committee For KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together With Pembrolizumab In Non-Small Cell Lung Cancer
Novocure Announces FDA IDE Approval and Steering Committee for KEYNOTE-B36 Trial Evaluating Tumor Treating Fields Together with Pembrolizumab in Non-Small Cell Lung Cancer
Novocure (NASDAQ:NVCR) today announced that the
Neovasc Highlights Presentations Across Germany Featuring Co.’s Reducer Product
Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve…